Macular Edema and Macular Degeneration Global Market Report 2025

Global Macular Edema and Macular Degeneration Market Report 2025

Macular Edema and Macular Degeneration Global Market Report 2025 – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration), By End User (Hospitals, Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Macular Edema and Macular Degeneration Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Macular Edema and Macular Degeneration Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Macular Edema and Macular Degeneration Global Market Report 2025

Proud Members Of

Macular Edema and Macular Degeneration Market Definition

Macular edema and Macular Degeneration are two different eye conditions that can affect vision. Macular edema is swelling in the part of the retina at the back of the eye, which can cause blurry vision. Macular degeneration is a condition that affects the macula, a part of the retina at the back of the eye that is responsible for central vision. They can be caused by many different conditions, including diabetic retinopathy, retinal vein occlusion, and inflammation, and include age, genetics, smoking, high blood pressure, and obesity.

The main types of macular edema and macular degeneration treatment include drug therapy and laser treatment. Drug therapy refers to the use of pharmaceutical drugs or medications to treat, manage, or alleviate medical conditions, diseases, or symptoms in individuals. It is used for various applications including macular edema, diabetic macular edema (DME), cystoid macular edema (CME), macular degeneration, dry age-related macular degeneration, and wet age-related macular degeneration by hospitals, clinics, and other end users.

Macular Edema and Macular Degeneration Market Segmentation

The macular edema and macular degeneration market covered in this report is segmented –

1) By Treatment Type: Drug Therapy, Laser Treatment

2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids)

2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy

Macular Edema and Macular Degeneration Market Size and growth rate 2025 to 2029: Graph

Macular Edema and Macular Degeneration Market Size 2025 And Growth Rate

The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $9.65 billion in 2024 to $10.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to aging population, prevalence of diabetes, awareness and early diagnosis, global initiatives in eye health, pharmaceutical innovations, patient advocacy and support.

Macular Edema and Macular Degeneration Market Growth Forecast

The macular edema and macular degeneration market size is expected to see strong growth in the next few years. It will grow to $13.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to personalized medicine approaches, rising awareness in emerging markets, focus on combination therapies, integration with teleophthalmology services, global aging demographics. Major trends in the forecast period include advancements in sustained-release drug delivery, integration of gene therapies, development of novel imaging technologies, personalized treatment approaches based on biomarkers, teleophthalmology for remote monitoring, advancements in artificial intelligence for diagnostics.

Book your 30 minutes free consultation with our research experts

Macular Edema and Macular Degeneration Market Driver: Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degeneration Market

The rising diabetes population is expected to propel the growth of the macular edema and macular degeneration market going forward. Diabetes is a chronic medical condition characterized by high glucose (sugar) levels in the blood. Diabetes damages the blood vessels in the eye, which can result in macular edema and macular degeneration. For instance, in June 2024, according to The National Health Service (NHS England), a UK-based publicly funded healthcare system, in 2023, the number of individuals identified by the NHS in England as having pre-diabetes rose to 3,615,330, marking an 18% increase from 3,065,825 in 2022. Additionally, among those under 40, cases surged nearly 25%, growing from 173,166 in 2022 to 216,440 in 2023. Therefore, the rising diabetes population is driving the growth of the macular edema and macular degeneration market.

Macular Edema and Macular Degeneration Market Driver: Increasing Prevalence Of Eye Disorders Fuels Growth In Macular Edema And Macular Degeneration Market

The increasing prevalence of eye disorders is expected to propel the growth of the macular edema and macular degeneration market going forward. Eye disorders encompass a wide range of conditions that affect the visual system, leading to vision impairment or other symptoms. Eye disorders can contribute to macular edema by leading to fluid leakage in the macula. The abnormal blood vessel growth and leakage characteristic of wet AMD contribute directly to fluid buildup in the macula. For instance, in September 2023, according to a report published by National Eye Health Week, a UK-based government website, the primary cause of blindness in the UK, late-stage age-related macular degeneration (AMD), is expected to increase by 25% by 2032, while early-stage AMD (drusen) will increase by 16%, cataracts by 25%, and glaucoma by 17% by 2032. Therefore, the increasing prevalence of eye disorders is driving the growth of the macular edema and macular degeneration market.

Global Macular Edema and Macular Degeneration Market Major Players

Major companies operating in the macular edema and macular degeneration market report are F. Hoffmann La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Bausch Health Companies Inc., Clover Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Samsung Bioepis Inc., PanOptica Inc., Regen X Bio Inc., Aerie Pharmaceutical Inc., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd., Alimera Sciences Inc., Kodiak Sciences Inc., Acucela Inc., Editas Medicine Inc., IVERIC bio Inc., Lineage Cell Therapeutics Inc., Allegro Ophthalmic Ltd., Ampio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Graybug Vision Inc., Clearside Biomedical Inc., Ocugen Inc., Opthea Limited

Global Macular Edema and Macular Degeneration Market Trend: Innovative Medication Advancements In The Macular Edema And Macular Degeneration Market

Major companies operating in the macular edema and macular degeneration market are focusing on developing innovative products such as Vabysmo (faricimab-svoa) to increase their profitability in the market. Vabysmo (faricimab-svoa) is a medication used for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). For instance, in January 2022, Genentech Inc., a US-based biotechnology corporation, got Vabysmo (faricimab-svoa) approval from the Food and Drug Administration. It is a bispecific antibody that targets vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2), making IT the first bispecific monoclonal antibody for both disorders. Faricimab has the potential to become a blockbuster medication for the treatment of nAMD and DME, and the FDA and EU approval of IT has been a significant milestone for Genentech and Roche.

Macular Edema and Macular Degeneration Market Merger And Acquisition: Merck Acquires Eyebiotech Limited To Enhance Eye Disease Therapy Pipeline

In July 2024, Merck And Co. Inc., a US-based pharmaceutical and biotechnology company, acquired Eyebiotech Limited (Eyebio) for an undisclosed amount. The aim of the acquisition is to strengthen and diversify Merck's late-stage pipeline by adding Restoret, a novel late-phase candidate for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (NVAMD). This acquisition enhances MSD's portfolio with innovative treatments based on novel biology and genetics, addressing unmet medical needs in retinal diseases. Eyebiotech Limited (eyebio) is a US-based ophthalmology biotechnology company that develops therapies to treat sight-threatening eye diseases, including macular edema and macular degeneration.

Regional Outlook For The Global Macular Edema and Macular Degeneration Market

North America was the largest region in the macular edema and macular degeneration market in 2024. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the macular edema and macular degeneration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Macular Edema and Macular Degeneration Market?

The macular edema and macular degeneration market consists of revenues earned by entities by providing services such as ophthalmic care, ophthalmologic evaluation, imaging and diagnostics, laser therapy, photodynamic therapy, and rehabilitation and low vision services. The market value includes the value of related goods sold by the service provider or included within the service offering. The macular edema and macular degeneration market also includes sales of surgical interventions, low vision aids, dietary supplements, retinal implants, and subretinal injections. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Macular Edema and Macular Degeneration Industry?

The macular edema and macular degeneration market research report is one of a series of new reports from The Business Research Company that provides macular edema and macular degeneration market statistics, including macular edema and macular degeneration industry global market size, regional shares, competitors with macular edema and macular degeneration market share, detailed macular edema and macular degeneration market segments, market trends and opportunities, and any further data you may need to thrive in the macular edema and macular degeneration industry. This macular edema and macular degeneration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Macular Edema and Macular Degeneration Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$10.43 billion
Revenue Forecast In 2034	$13.71 billion
Growth Rate	CAGR of 7.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Treatment Type: Drug Therapy, Laser Treatment 2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration 3) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids) 2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Bausch Health Companies Inc., Clover Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Samsung Bioepis Inc., PanOptica Inc., Regen X Bio Inc., Aerie Pharmaceutical Inc., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd., Alimera Sciences Inc., Kodiak Sciences Inc., Acucela Inc., Editas Medicine Inc., IVERIC bio Inc., Lineage Cell Therapeutics Inc., Allegro Ophthalmics Ltd., Ampio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Graybug Vision Inc., Clearside Biomedical Inc., Ocugen Inc., Opthea Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Macular Edema and Macular Degeneration Market Characteristics

3. Macular Edema and Macular Degeneration Market Trends And Strategies

4. Macular Edema and Macular Degeneration Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Macular Edema and Macular Degeneration Growth Analysis And Strategic Analysis Framework

5.1. Global Macular Edema and Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Macular Edema and Macular Degeneration Market Growth Rate Analysis

5.4. Global Macular Edema and Macular Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Macular Edema and Macular Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Macular Edema and Macular Degeneration Total Addressable Market (TAM)

6. Macular Edema and Macular Degeneration Market Segmentation

6.1. Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Therapy

Laser Treatment

6.2. Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Macular Edema

Diabetic Macular Edema (DME)

Cystoid Macular Edema (CME)

Macular Degeneration

Dry age-related macular degeneration

Wet age-related macular degeneration

6.3. Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.4. Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-VEGF (Vascular Endothelial Growth Factor) Injections

Steroid Injections

Oral Medications

Combination Therapy (Anti-VEGF + Steroids)

6.5. Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Focal Laser Photocoagulation

Panretinal Photocoagulation (PRP)

Subthreshold Laser Therapy

MicroPulse Laser Therapy

7. Macular Edema and Macular Degeneration Market Regional And Country Analysis

7.1. Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Macular Edema and Macular Degeneration Market

8.1. Asia-Pacific Macular Edema and Macular Degeneration Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Macular Edema and Macular Degeneration Market

9.1. China Macular Edema and Macular Degeneration Market Overview

9.2. China Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Macular Edema and Macular Degeneration Market

10.1. India Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Macular Edema and Macular Degeneration Market

11.1. Japan Macular Edema and Macular Degeneration Market Overview

11.2. Japan Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Macular Edema and Macular Degeneration Market

12.1. Australia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Macular Edema and Macular Degeneration Market

13.1. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Macular Edema and Macular Degeneration Market

14.1. South Korea Macular Edema and Macular Degeneration Market Overview

14.2. South Korea Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Macular Edema and Macular Degeneration Market

15.1. Western Europe Macular Edema and Macular Degeneration Market Overview

15.2. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Macular Edema and Macular Degeneration Market

16.1. UK Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Macular Edema and Macular Degeneration Market

17.1. Germany Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Macular Edema and Macular Degeneration Market

18.1. France Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Macular Edema and Macular Degeneration Market

19.1. Italy Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Macular Edema and Macular Degeneration Market

20.1. Spain Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Macular Edema and Macular Degeneration Market

21.1. Eastern Europe Macular Edema and Macular Degeneration Market Overview

21.2. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Macular Edema and Macular Degeneration Market

22.1. Russia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Macular Edema and Macular Degeneration Market

23.1. North America Macular Edema and Macular Degeneration Market Overview

23.2. North America Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Macular Edema and Macular Degeneration Market

24.1. USA Macular Edema and Macular Degeneration Market Overview

24.2. USA Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Macular Edema and Macular Degeneration Market

25.1. Canada Macular Edema and Macular Degeneration Market Overview

25.2. Canada Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Macular Edema and Macular Degeneration Market

26.1. South America Macular Edema and Macular Degeneration Market Overview

26.2. South America Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Macular Edema and Macular Degeneration Market

27.1. Brazil Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Macular Edema and Macular Degeneration Market

28.1. Middle East Macular Edema and Macular Degeneration Market Overview

28.2. Middle East Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Macular Edema and Macular Degeneration Market

29.1. Africa Macular Edema and Macular Degeneration Market Overview

29.2. Africa Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Macular Edema and Macular Degeneration Market Competitive Landscape And Company Profiles

30.1. Macular Edema and Macular Degeneration Market Competitive Landscape

30.2. Macular Edema and Macular Degeneration Market Company Profiles

30.2.1. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Macular Edema and Macular Degeneration Market Other Major And Innovative Companies

31.1. Amgen Inc.

31.2. Regeneron Pharmaceuticals Inc.

31.3. Biogen Inc.

31.4. Bausch Health Companies Inc.

31.5. Clover Therapeutics Inc.

31.6. Santen Pharmaceutical Co. Ltd.

31.7. Samsung Bioepis Inc.

31.8. PanOptica Inc.

31.9. Regen X Bio Inc.

31.10. Aerie Pharmaceutical Inc.

31.11. Apellis Pharmaceuticals Inc.

31.12. Kubota Pharmaceutical Holdings Co. Ltd.

31.13. Alimera Sciences Inc.

31.14. Kodiak Sciences Inc.

31.15. Acucela Inc.

32. Global Macular Edema and Macular Degeneration Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Macular Edema and Macular Degeneration Market

34. Recent Developments In The Macular Edema and Macular Degeneration Market

35. Macular Edema and Macular Degeneration Market High Potential Countries, Segments and Strategies

35.1 Macular Edema and Macular Degeneration Market In 2029 - Countries Offering Most New Opportunities

35.2 Macular Edema and Macular Degeneration Market In 2029 - Segments Offering Most New Opportunities

35.3 Macular Edema and Macular Degeneration Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: F. Hoffmann La Roche Ltd. Financial Performance

Table 77: Abbvie Inc. Financial Performance

Table 78: Bayer AG Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: GlaxoSmithKline plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: F. Hoffmann La Roche Ltd. Financial Performance

Figure 77: Abbvie Inc. Financial Performance

Figure 78: Bayer AG Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: GlaxoSmithKline plc Financial Performance

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

Blood Warmers Global Market Report 2024 – By Type (Portable blood warmers, Non-portable blood warmers), By Application (Surgery, Acute care, Newborn care, Homecare, Other Applications), By End-User (Hospitals Or Clinics, Ambulatory services, Defense forces, Rescue forces) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Brain Implants Global Market Report 2024 – By Product (Deep Brain Stimulator, Spinal Cord Stimulator, Vagus Nerve Stimulator), By Application (Chronic Pain, Epilepsy, Parkinson’s Disease, Depression, Essential Tremor, Alzheimer’s Disease), By End User (Hospitals, Neurology Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Instrumentation Valves And Fittings Global Market Report 2024 – By Product (Valves, Fittings, Actuators, Other Products), By Material (Alloy, Cast Iron, Stainless Steel, Other Materials), By Industry (Chemicals, Energy And Power, Healthcare, Oil And Gas, Pulp And Paper, Other Industries) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Lice Treatment Global Market Report 2024 – By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis), By Treatment (Over The Counter (OTC) Medication, Prescription Medication), By Distribution Channel (Hospitals And Clinics, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Foldable Houses Global Market Report 2025 – By Construction Type (Single Section, Multi-Section), By Architecture Type (Slope Roof, Flat Roof), By End-User (Single Family, Multi-Family) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Macular Edema and Macular Degeneration market?

Macular edema and macular degeneration are two different eye conditions that can affect vision. Macular edema is swelling in the part of the retina at the back of the eye, which can cause blurry vision. Macular degeneration is a condition that affects the macula, a part of the retina at the back of the eye that is responsible for central vision. They can be caused by many different conditions, including diabetic retinopathy, retinal vein occlusion, and inflammation, and include age, genetics, smoking, high blood pressure, and obesity. For further insights on the Macular Edema and Macular Degeneration market, request a sample here

How will the Macular Edema and Macular Degeneration market drivers and restraints affect the market dynamics? What forces will shape the Macular Edema and Macular Degeneration industry going forward?

The Macular Edema and Macular Degeneration market major growth driver - Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degeneration Market. For further insights on the Macular Edema and Macular Degeneration market, request a sample here

What is the forecast market size or the forecast market value of the Macular Edema and Macular Degeneration market?

The Macular Edema and Macular Degeneration market size has grown strongly in recent years. The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $9.65 billion in 2024 to $10.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to aging population, prevalence of diabetes, awareness and early diagnosis, global initiatives in eye health, pharmaceutical innovations, patient advocacy and support. The macular edema and macular degeneration market size is expected to see strong growth in the next few years. It will grow to $13.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to personalized medicine approaches, rising awareness in emerging markets, focus on combination therapies, integration with teleophthalmology services, global aging demographics. Major trends in the forecast period include advancements in sustained-release drug delivery, integration of gene therapies, development of novel imaging technologies, personalized treatment approaches based on biomarkers, teleophthalmology for remote monitoring, advancements in artificial intelligence for diagnostics. For further insights on the Macular Edema and Macular Degeneration market, request a sample here

How is the Macular Edema and Macular Degeneration market segmented?

The macular edema and macular degeneration market covered in this report is segmented –
1) By Treatment Type: Drug Therapy, Laser Treatment
2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids)
2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy For further insights on the Macular Edema and Macular Degeneration market, request a sample here

Which region has the largest share of the Macular Edema and Macular Degeneration market? What are the other regions covered in the report?

North America was the largest region in the macular edema and macular degeneration market in 2024. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Macular Edema and Macular Degeneration market, request a sample here.

Who are the major players in the Macular Edema and Macular Degeneration market?

What are the key trends in the Macular Edema and Macular Degeneration market?

Major trends in the Macular Edema and Macular Degeneration market include Innovative Medication Advancements In The Macular Edema And Macular Degeneration Market. For further insights on the Macular Edema and Macular Degeneration market, request a sample here.

What are the major opportunities in the Macular Edema and Macular Degeneration market? What are the strategies for the Macular Edema and Macular Degeneration market?

For detailed insights on the major opportunities and strategies in the Macular Edema and Macular Degeneration market, request a sample here.

How does the Macular Edema and Macular Degeneration market relate to the overall economy and other similar markets?

For detailed insights on Macular Edema and Macular Degeneration's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Macular Edema and Macular Degeneration industry?

For detailed insights on the mergers and acquisitions in the Macular Edema and Macular Degeneration industry, request a sample here.

What are the key dynamics influencing the Macular Edema and Macular Degeneration market growth? SWOT analysis of the Macular Edema and Macular Degeneration market.

For detailed insights on the key dynamics influencing the Macular Edema and Macular Degeneration market growth and SWOT analysis of the Macular Edema and Macular Degeneration industry, request a sample here.